ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

33 hedge funds and large institutions have $277M invested in Aclaris Therapeutics in 2015 Q4 according to their latest regulatory filings, with 33 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
+33
Holders Change %
–
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
33
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$102M
2
RCM
2
RA Capital Management
Massachusetts
$69.1M
3
Franklin Resources
3
Franklin Resources
California
$44.6M
4
RSCM
4
Rock Springs Capital Management
Maryland
$24.1M
5
CAM
5
Cormorant Asset Management
Massachusetts
$17.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$45K +$45K +1,660 New
Deutsche Bank
27
Deutsche Bank
Germany
$38K +$38K +1,446 New
BNP Paribas Financial Markets
28
BNP Paribas Financial Markets
France
$28K +$28K +1,038 New
Barclays
29
Barclays
United Kingdom
$26K +$26K +1,000 New
TRCT
30
Tower Research Capital (TRC)
New York
$22K +$22K +812 New
Morgan Stanley
31
Morgan Stanley
New York
$11K +$11K +391 New
Bank of America
32
Bank of America
North Carolina
$4K +$4K +139 New
UBS Group
33
UBS Group
Switzerland
$3K +$3K +109 New
1
2